In Reply We appreciate the correspondence from O’Hanlon and colleagues regarding our systematic review of population-based quality indicators (QIs) for end-of-life cancer care.1 We are aware of the extensive and noteworthy research this expert team has contributed to the field of quality measurement and palliative care. Our responses to their comments follow.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Henson LA, Gao W. Shortlist of Quality Indicators for End-of-Life Cancer Care—Reply. JAMA Oncol. Published online May 14, 2020. doi:10.1001/jamaoncol.2020.1162
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: